CAU
GH icon

Caxton Associates (UK)’s Guardant Health GH Stock Holding History

Caxton Associates (UK)’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
20,127
+11,128
+124% +$1.21M 0.06% 164
2026
Q1 		$831K Buy
+8,999
New +$904K 0.02% 414

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Caxton Associates (UK)'s GH Position: Q2 2026 in Review

Caxton Associates (UK) increased its Guardant Health (GH) stake by 124% in Q2 2026, buying an estimated $1.21M and bringing the position to 20,127 shares worth $3.02M. The position accounts for 0.06% of the portfolio, ranked #164.

Caxton Associates (UK) first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Caxton Associates (UK) held 20,127 shares of Guardant Health worth $3.02M as of Q2 2026.
  • Caxton Associates (UK) bought 11,128 Guardant Health shares in Q2 2026, an estimated $1.21M.
  • Guardant Health made up 0.06% of Caxton Associates (UK)'s portfolio in Q2 2026, its #164 holding.
  • Caxton Associates (UK) first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.